Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

AEZS

Aeterna Zentaris (AEZS)

Aeterna Zentaris Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:AEZS
DateHeureSourceTitreSymboleSociété
01/05/202413h55GlobeNewswire Inc.Aeterna Zentaris Announces Effective Date of Share ConsolidationNASDAQ:AEZSAeterna Zentaris Inc
28/03/202412h55GlobeNewswire Inc.Ceapro Receives Final Court Approval for Merger with Aeterna ZentarisNASDAQ:AEZSAeterna Zentaris Inc
27/03/202413h05GlobeNewswire Inc.Aeterna Zentaris Reports Fourth Quarter and Full Year 2023 Financial Results and Announces Completion of Enrollment in Ongoing Pivotal DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone DeficiencyNASDAQ:AEZSAeterna Zentaris Inc
12/03/202419h10GlobeNewswire Inc.Aeterna Zentaris and Ceapro Merger Approved by Securityholders at Special MeetingsNASDAQ:AEZSAeterna Zentaris Inc
26/02/202413h30GlobeNewswire Inc.Leading Independent Proxy Advisory Firm ISS Recommends Aeterna Zentaris and Ceapro Securityholders Vote FOR the Arrangement Agreement to Approve the Merger of Equals to Create a Diversified Biopharmaceutical CompanyNASDAQ:AEZSAeterna Zentaris Inc
15/02/202423h50GlobeNewswire Inc.Aeterna Zentaris Issues Letter to Shareholders and Management Proxy Circular Ahead of Special Meeting of Shareholders to Approve Merger of Equals with CeaproNASDAQ:AEZSAeterna Zentaris Inc
15/02/202422h54Edgar (US Regulatory)Form F-1 - Registration statement for certain foreign private issuersNASDAQ:AEZSAeterna Zentaris Inc
15/02/202415h33Edgar (US Regulatory)Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]NASDAQ:AEZSAeterna Zentaris Inc
22/12/202322h42Edgar (US Regulatory)Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]NASDAQ:AEZSAeterna Zentaris Inc
14/12/202313h50Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:AEZSAeterna Zentaris Inc
14/12/202313h50GlobeNewswire Inc.Aeterna Zentaris and Ceapro Announce Merger of Equals to Create a Diversified Biopharmaceutical CompanyNASDAQ:AEZSAeterna Zentaris Inc
09/11/202314h00GlobeNewswire Inc.Aeterna Zentaris Reports Third Quarter 2023 Financial ResultsNASDAQ:AEZSAeterna Zentaris Inc
11/10/202314h00GlobeNewswire Inc.Aeterna Zentaris to Participate at the Virtual Investor Ask the CEO ConferenceNASDAQ:AEZSAeterna Zentaris Inc
05/09/202314h00GlobeNewswire Inc.Aeterna Zentaris to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:AEZSAeterna Zentaris Inc
09/08/202314h05GlobeNewswire Inc.Aeterna Zentaris Reports Second Quarter 2023 Financial ResultsNASDAQ:AEZSAeterna Zentaris Inc
13/07/202313h30GlobeNewswire Inc.Aeterna Zentaris Outlines Progress on Development Pipeline Programs and Provides Corporate UpdateNASDAQ:AEZSAeterna Zentaris Inc
05/07/202314h45GlobeNewswire Inc.Aeterna Zentaris to Participate in the Virtual Investor Summer Spotlight SeriesNASDAQ:AEZSAeterna Zentaris Inc
14/06/202322h43Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AEZSAeterna Zentaris Inc
14/06/202322h05GlobeNewswire Inc.Aeterna Zentaris Announces Results of Virtual 2023 Meeting of ShareholdersNASDAQ:AEZSAeterna Zentaris Inc
15/05/202322h05GlobeNewswire Inc.Aeterna Zentaris Announces Virtual 2023 Meeting of ShareholdersNASDAQ:AEZSAeterna Zentaris Inc
11/05/202312h07Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:AEZSAeterna Zentaris Inc
09/05/202323h00GlobeNewswire Inc.Aeterna Zentaris Reports First Quarter 2023 Financial ResultsNASDAQ:AEZSAeterna Zentaris Inc
05/04/202313h55GlobeNewswire Inc.Aeterna Zentaris Provides Update on Macrilen® (Macimorelin), Reiterates Advancement of Pediatric DETECT TrialNASDAQ:AEZSAeterna Zentaris Inc
23/03/202313h08Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:AEZSAeterna Zentaris Inc
23/03/202313h05GlobeNewswire Inc.Aeterna Zentaris Reports Fourth Quarter and Full Year 2022 Financial ResultsNASDAQ:AEZSAeterna Zentaris Inc
16/03/202313h05GlobeNewswire Inc.Pharmanovia to Market GHRYVELIN™ (Macimorelin) in the European Economic Area (EEA) and UK as Diagnostic Test for Growth Hormone Deficiency (GHD)NASDAQ:AEZSAeterna Zentaris Inc
17/01/202314h05GlobeNewswire Inc.Aeterna Zentaris Provides Business Update and Outlines Key Upcoming MilestonesNASDAQ:AEZSAeterna Zentaris Inc
10/01/202314h05GlobeNewswire Inc.Aeterna Zentaris to Present at the Virtual Investor 2023 Companies to Watch EventNASDAQ:AEZSAeterna Zentaris Inc
03/11/202213h05GlobeNewswire Inc.Aeterna Zentaris Reports Third Quarter 2022 Financial ResultsNASDAQ:AEZSAeterna Zentaris Inc
06/09/202212h15TipRanksH.C. Wainwright Reaffirms Their Buy Rating on Aeterna Zentaris (AEZS)NASDAQ:AEZSAeterna Zentaris Inc
 Showing the most relevant articles for your search:NASDAQ:AEZS